Fig. 1From: Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patientsCumulative incidence of cardiac events in LQT1 and LQT2 patients by gender before initiation of β-blocker treatment at the age of 18–40 yearsBack to article page